Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NEOGENOMICS INC Director's Dealing 2026

Jan 5, 2026

32227_dirs_2026-01-05_ec695aca-e8e6-431e-a139-2a3fb454f907.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2026-01-01

Reporting Person: Kenny John P. (Director)

More from NEOGENOMICS INC

Board/Management Information 2026
Jun 25
Capital/Financing Update 2026
Jun 22
Capital/Financing Update 2026
Jun 17
Regulatory Filings 2026
Jun 15
Call Transcript 2026
Jun 4
Declaration of Voting Results & Voting Rights Announcements 2026
May 22
Call Transcript 2026
May 21
Call Transcript 2026
May 12
Interim / Quarterly Report 2026
Apr 28
Call Transcript 2026
Apr 28
View all filings →